Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,317
Total Claims
$1.1M
Drug Cost
481
Beneficiaries
$2,231
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+33%
Opioid rate vs peers
3.4% vs 2.6% avg
+109%
Cost per patient vs peers
$2,231 vs $1,068 avg
+79%
Brand preference vs peers
16.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.4%
Opioid Rate
320
Opioid Claims
$3,307
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,482 claims · $899K
Generic: 7,719 claims · $169K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 79 | $112K |
| Semaglutide | 63 | $76K |
| Insulin Glargine,hum.Rec.Anlog | 98 | $70K |
| Empagliflozin | 61 | $64K |
| Dapagliflozin Propanediol | 68 | $56K |
| Apixaban | 56 | $46K |
| Umeclidinium Brm/Vilanterol Tr | 78 | $45K |
| Insulin Lispro | 29 | $34K |
| Budesonide/Formoterol Fumarate | 59 | $27K |
| Fluticasone Propion/Salmeterol | 48 | $27K |
| Sitagliptin Phos/Metformin Hcl | 31 | $27K |
| Ipratropium/Albuterol Sulfate | 25 | $25K |
| Insulin Detemir | 35 | $22K |
| Sitagliptin Phos/Metformin Hcl | 16 | $21K |
| Sitagliptin Phosphate | 12 | $21K |
Prescribing Profile
Patient Profile
66
Avg Age
63%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data